Quality of life assessment in a chemoprevention trial: Fenretinide and oral or transdermal HRT
To access this article, please choose from the options below
PII: S0378-5122(06)00009-0
doi:10.1016/j.maturitas.2006.01.005
© 2006 Elsevier Ireland Ltd. All rights reserved.
